Status:
COMPLETED
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease
Lead Sponsor:
Cardenal Herrera University
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study is a double blinded randomized clinical trial with two arms which aims to study the effects of diaphragmatic myofascial release in patients with gastroesophageal reflux disease (GERD). GER...
Eligibility Criteria
Inclusion
- Patients with the diagnostic of GERD
Exclusion
- hiatal hernia \>2 cm
- previous operation at the LES
- actual erosive esophagitis
- Congenital or acquired immune disorders.
- Allergic status of any kind.
- Systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine including diabetes, metabolic and neoplastic).
- Leukemia.
- Severe psychiatric disorders.
- Neuromuscular or neurological injuries.
- Aneurysms.
- Abdominal or spine surgery.
- Vertebral fractures.
- Osteoporosis (advanced stage).
- Acute lesions of soft tissues or in an inflammatory state.
- Open wounds.
- Pregnancy.
- Intrauterine device.
- Patients with corticosteroid therapy.
- Hemophilia or treatment with anticoagulant therapy.
- Hypersensitivity of the skin or dermatological diseases in the trunk that impossibilities the application of the techniques.
- Rejection of manual contact.
- Non-Spanish speaking patients.
- Patients who have previously received some treatment of myofascial release.
Key Trial Info
Start Date :
October 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03299985
Start Date
October 5 2017
End Date
March 15 2018
Last Update
October 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad CEU Cardenal Herrera
Valencia, Spain, 46113